|
|
|
The Handbook of Experimental Pharmacology is now published
The Springer Handbook Good Research Practice in Non-Clinical Pharmacology and Biomedicine on quality in preclinical research has just been published. The book was edited by EQIPD investigators Anton Bespalov, Martin C. Michel, Thomas Steckler and many other EQIPD members contributed as authors.
You can download for free individual chapters or the whole book by clicking on this link.
Discover more about the EQIPD project here.
|
|
|
|
Campfire Session – 33rd ECNP Congress, 12-15 September
The EQIPD project will be featured in one of the ECNP Congress ‘Campfire Sessions’. Lucas Noldus will discuss how to improve quality in preclinical data without getting lost in clinical translation. The session is scheduled for 14 September 2020 at 9.45am CET.
The intimate setup of the session provides useful opportunities to join in discussion, ask questions and brainstorm.
Find out more about the session by reading the outline and biography of the speaker here.
|
|
|
|
2020 Best Negative Data Prize: call for submissions
The Global Preclinical Data Forum (GPDF), a partnership of Cohen Veterans Bioscience (CVB), a non-profit research biotech, and the European College of Neuropsychopharmacology (ECNP), invite you to submit your publications with ‘negative’ results– where the data do not confirm the expected outcomes or original hypotheses – in neuroscience research.
The award will be conferred at the 33rd ECNP Congress, 12-15 September 2020, where the winner will be invited to present a talk about his or her negative data results paper.
The winner will receive a prize of € 10,000 made available through the support provided by CVB.
How to apply
Corresponding authors may submit their papers directly on the GDPF website.
|
|
|
|
Special report: neuroscience
The EQIPD project was highlighted on a recent publication by DDNews. Lucas Noldus from Noldus Information Technology, one of the 29 partners of the EQIPD project, gave an interview that focused on trends in preclinical behavioural research and the problems of translational validity and reproducibility of behavioural testing.
Read the complete report here and see page three for the specific reference to the EQIPD project.
DDNews is a magazine with 30,000 subscribers in drug discovery research.
|
|
|
|
Join us on social media…
If you would like to directly interact with members of the project, join the EQIPD LinkedIn group here.
EQIPD also has a Facebook account, we invite you to follow us.
You can also stay updated on the development of the project by following us on Twitter.
Remember...
Are you posting about the EQIPD project? Please remember to use the hashtag #EQIPD. Thank you!
|
|
|
|
|
|
